Therapeutic Effect of Rhpth (1-34) on Glucocorticoid-Induced Osteoporosis in Rats

金慰芳,王洪复,顾淑珠,周轶,高建军,徐培康,徐爱红,王漪,周永春

DOI: https://doi.org/10.3969/j.issn.1006-7108.2004.04.020

2004-01-01

Abstract:Objective To investigate the therapeutic effect of recombinant human parathyroid hormone(1-34)[rhPTH(1-34) ] on osteoporosis induced by glucocorticoid in rats. Methods The osteoporosis rat model was developed by intramusculr dexamethasone, and then rhPTH(1-34)5, 10, 20, and 40 μg/kg was subcutaneously injected once daily for 8 weeks. The dry weight and ash weight of bone, bone mineral density, bone biomechanical property, trabecular area, bone mineral deposition and the biochemistry of serum and urine related bone metabolites were measured after the termination of therapy. Results In rhPTH( 1-34)-treated rats, bone mass, bone biomechanical property, trabecular area, and bone depositon increased significantly, compared with the control group ( P 0.05 - 0.001), but serum Ca and P had no marked change. Conclusions rhPTH(1-34) possesses remarkable therapeutic effect on glucocorticoid-induced osteoporosis in rats.